Novartis broke sacred FDA rule: In God we trust, all others must bring data

Novartis broke sacred FDA rule: In God we trust, all others must bring data

Opinion: Novartis violated FDA’s sacred principle: In God we trust, all others must bring data

By ROBERT M. CALIFF

ANDREW HARNIK/AP

The FDA's independent evaluation of science is an essential part of its dual role in protecting public health and promoting innovation.

READ MORE